Description
Provided is a Glucagon-like peptide-1 receptor (GLP-1R) agonist. It may be used in administerment to a mammal in need of such treatment a composition comprising a glucagon-like peptide-1 receptor (GLP-1R) agonist in an amount effective for activating GLP-1R, thereby reducing leukocyte invasion of a tissue of the central nervous system.
Target
GLP1R
Target Alias Names
GLP1R, glucagon-like peptide 1 receptor, GLP-1R, GLP-1-R, GLP-1 receptor
Isotype/Mimetic
Humanized IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression